Edwards Lifesciences Corp (EW)

83.34
1.90 2.30
NYSE : Health Care
Prev Close 81.47
Open 81.50
Day Low/High 81.25 / 84.66
52 Wk Low/High 72.20 / 121.75
Volume 2.11M
Avg Volume 2.09M
Exchange NYSE
Shares Outstanding 213.81M
Market Cap 17.71B
EPS 2.30
P/E Ratio 32.75
Div & Yield N.A. (N.A)

Latest News

'Mad Money' Lightning Round: Brighter View for Some Insurers

'Mad Money' Lightning Round: Brighter View for Some Insurers

Jim Cramer says UVE is not bad, and he likes AIG and ALL as well.

Jim Cramer's 'Mad Money' Recap: Credibility Is the Most Valuable Currency for Investors

Jim Cramer's 'Mad Money' Recap: Credibility Is the Most Valuable Currency for Investors

Jim Cramer names companies with credibility, like NXPI and AAPL, and those that don't have it, including FIT.

Bullish and Bearish Reversals for the Week

Bullish and Bearish Reversals for the Week

Here's a window into what institutional investors may be doing and how to profit from that.

NXPI, AAPL, C: Jim Cramer's Views

NXPI, AAPL, C: Jim Cramer's Views

Cramer shares his views on takeover talks. NXP Semiconductor, Apple and Citigroup are among the stocks discussed.

Jim Cramer's 'Mad Money' Recap: Demand and Takeover Talk Lift Stocks

Jim Cramer's 'Mad Money' Recap: Demand and Takeover Talk Lift Stocks

Strong demand drives results and gains for Boeing, Akamai and others.

Cramer: Demand Lifts Defense, Aerospace, Cyber-Security, Regional Bank Stocks

Cramer: Demand Lifts Defense, Aerospace, Cyber-Security, Regional Bank Stocks

But several airline and retail stocks are proving highly volatile.

Edwards Lifesciences (EW) Stock Tumbles on Q3 Revenue Miss

Edwards Lifesciences (EW) Stock Tumbles on Q3 Revenue Miss

Edwards Lifesciences' (EW) 2016 third quarter revenue fell short of analysts' estimates.

Jim Cramer -- Edwards Lifesciences Is a Buy

Jim Cramer -- Edwards Lifesciences Is a Buy

Edwards Lifesciences is plunging on its earnings results. Cramer says investors should buy it.

Trader's Daily Notebook: Market Keeps Doing the Horizontal Flop

You can't blame weak earnings.

Boston Scientific Remains Disciplined Buyer in Light of Large-scale Industry Consolidation

Boston Scientific Remains Disciplined Buyer in Light of Large-scale Industry Consolidation

The medical devices company is likely to stick to small- to mid- sized M&A unless it finds itself the target.

4 Charts That Are Working Now

4 Charts That Are Working Now

Work done now could lead to a big payoff if you're patient.

How Chart Analysis Tops Fundamental Analysis

How Chart Analysis Tops Fundamental Analysis

Forget about P/E ratios; 'cheap' stocks are cheap for a reason.

Jim Cramer's 'Mad Money' Recap: Why You Shouldn't Be Jumping In and Out of Stocks

Jim Cramer's 'Mad Money' Recap: Why You Shouldn't Be Jumping In and Out of Stocks

This is not the time to sell in a panic, Cramer says.

Cramer: 10 Stocks (Plus 2) to Own for When, not If, the Fed Raises Rates

Cramer: 10 Stocks (Plus 2) to Own for When, not If, the Fed Raises Rates

These are my top fall-and-rise stories for the 10 days leading up to and immediately following next week's Federal Reserve meeting.

Edwards Lifesciences Is Not Missing a Beat

Edwards Lifesciences Is Not Missing a Beat

Edwards Lifesciences is one of the best-performing stocks in the health care sector. Year to date, the stock is up 47%. Can it continue to climb?

No Longer a Beauty: It's Time to Ditch Ulta

No Longer a Beauty: It's Time to Ditch Ulta

But these 3 other stocks are looking good for buys.

Edwards Lifesciences Becomes #221 Most Shorted S&P 500 Component, Replacing Becton, Dickinson

Edwards Lifesciences Becomes #221 Most Shorted S&P 500 Component, Replacing Becton, Dickinson

The most recent short interest data has been released for the 08/15/2016 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

'Mad Money' Lightning Round: Buy Edwards Lifesciences, Five Below

'Mad Money' Lightning Round: Buy Edwards Lifesciences, Five Below

Cramer is taking a pass on Rapid7 and is staying away from Shake Shack.

Jim Cramer's 'Mad Money' Recap: What to Buy During the Next 'Flash Crash'

Jim Cramer's 'Mad Money' Recap: What to Buy During the Next 'Flash Crash'

We've seen it before and we'll see it again, Cramer says. Here's how to profit from the next flash crash.

Insider Trading Alert - STS, HLF And EW Traded By Insiders

Insider Trading Alert - STS, HLF And EW Traded By Insiders

Stocks with insider trader activity include STS, HLF and EW